BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025)
BioNTech SE (BNTX) posted Other Non Operating Income of -$452783.9 for Q2 2025, up 98.34% sequentially from -$27.3 million in Q1 2025, and up 83.18% YoY from -$247177.4 in Q2 2024.
BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025) Analysis & Trends
BioNTech SE has reported Other Non Operating Income for 6 years, with the latest figure at -$452783.9 in Q2 2025.
- Quarterly Other Non Operating Income rose 83.18% year-over-year to -$452783.9 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$33.5 million (down 194.48% YoY) and the FY2023 annual result came in at $188.8 million, up 176.8% from the prior year.
- Other Non Operating Income climbed to -$452783.9 in Q2 2025 per BNTX's latest filing, from -$27.3 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $121.6 million in Q2 2022 and troughed at -$329.8 million in Q4 2022.
- A 5-year average of $2.8 million and a median of $8.3 million in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 312.29% in 2022, down 4161.05% in 2022.
- Over 5 years, Other Non Operating Income stood at $8.1 million in 2021, then tumbled by 4161.05% to -$329.8 million in 2022, then soared by 93.08% to -$22.8 million in 2023, then jumped by 87.0% to -$3.0 million in 2024, then soared by 84.73% to -$452783.9 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$452783.9, -$27.3 million, and -$3.0 million for Q2 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -452,783.88 |
| Mar 31, 2025 | -27.35 Mn |
| Sep 30, 2024 | -2.97 Mn |
| Jun 30, 2024 | -2.69 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Dec 31, 2023 | -22.81 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 28.09 Mn |
| Mar 31, 2023 | 81.79 Mn |
| Dec 31, 2022 | -329.85 Mn |
| Sep 30, 2022 | 82.98 Mn |
| Jun 30, 2022 | 121.64 Mn |
| Mar 31, 2022 | 34.01 Mn |
| Dec 31, 2021 | 8.12 Mn |
| Sep 30, 2021 | 30.66 Mn |
| Jun 30, 2021 | 29.50 Mn |
| Sep 30, 2020 | -16.35 Mn |